About the region

Axonova is strategically located in Mauritius. This location offers multiple advantages, such as access to a rich and large pharmacopeia.

Mauritius and surrounding islands of the Indian Ocean form a unique biodiversity hotspot. The region is home to more than 15,000 species of plants, over 80% of which are endemic or known to exist nowhere else on earth. Mauritius has also an exclusive maritime zone of 2.3 million km2 harboring a variety of under-explored species.

Axonova’s vocation is to explore the vast reservoir of natural resources present in the region and translate this unique biodiversity into health products and therapeutics for use worldwide.

Management team

Fabien Boulle (PhD, MBA)

Chief Executive Officer

Fabien is a neuropharmacologist who cumulates more than 5 years of experience in the field of neurosciences and drug development (INSERM, Maastricht University, Servier). In particular, he has been working on the implication of BDNF/TrkB signaling in the pathophysiology and treatment of CNS disorders, and is co-author of 10 peer-reviewed articles in international scientific journals.

During the past 5 years, Fabien has held several positions in business development and entrepreneurship. He has worked as business developer at Brightlands (The Netherlands), where he was responsible for licensing IP from University and developing new start-ups in the field of biotechnology. He founded Axonova in 2017 and is the CEO of the company.

Fabien holds a joint European PhD degree in Neuropharmacology from Paris-Descartes University and Maastricht University, as well as a MBA degree in Management of Biotechnology from Ionis School of Technology and Management in Paris.

Shameem Fawdar (PhD)

Chief Scientific Officer

Shameem has over 10 years of experience in the fields of stem cell and cancer research (University of Westminster, Manchester Cancer Research UK Institute, CBBR-Mauritius) and is a published author in peer-reviewed scientific journals and books. With strong scientific experience from the UK and expertise in project design and management, she currently heads the Drug Discovery unit at Axonova.

Shameem’s work in science has been recognized locally and internationally and is the winner of the Best Young Mauritian Scientist Award (2015) and UNESCO-MERCK Women in Science Award (2017). She also sits on the board of directors of the Economic Development Board (Mauritius) and is a member of the Organization for Women in Science in the Developing World (OWSD Mauritius Chapter).

Shameem holds a PhD  in Stem Cell and Cancer Biology from the University of Westminster, London, UK.